scholarly works

Permanent URI for this collectionhttps://repository.ui.edu.ng/handle/123456789/526

Browse

Subject: search.filters.subject.IgA

Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Chlamydia trachomatis infection among pelvic inflammatory disease patients attending the gynaecology clinic of a private tertiary hospital in Ogun State, Nigeria.
    (2024) Ajani, T. A.; Elikwu, C. J.; Makanjuola, O. B.; Okangba, C. C.; Oluwasola, T. A.; Anaedobe, C. G.
    Background: Pelvic inflammatory disease (PID) is one of the very serious complications arising from sexually transmitted infections (STIs) and Chlamydia trachomatis has been implicated as one of the commonest causes of STI. Considering the adverse sequelae of PID, there is a need for locally relevant data which will guide preventive and therapeutic efforts. Detection of a combination of immunoglobulin G (IgG) and immunoglobulin A (IgA) has been described as an indicator of an actively chronic infection Aims: The aim of this study was to determine the prevalence of Chlamydia trachomatis infection by the use of IgA and IgG and evaluate the associated risk factors among females that presented with Pelvic inflammatory disease at the gynaecology clinic of Babcock University Teaching Hospital. Ilishan-Remo, Ogun State, Nigeria. (BUTH) Materials and Methods: This was a hospital–based, case-controlled study involving 44 patients diagnosed with PID and 44 age-matched controls at the gynaecology clinic of BUTHI. Interviewer-administered questionnaires were used to obtain information on socio-demographic characteristics, and risk factors for PID, from consenting participants. Blood samples were collected from each participant and analysed, using the enzyme-linked immunosorbent assay, for Chlamydia trachomatis type specific for IgA and IgG. Analysis was done by SPSS, IBM version 23.0 Results: Both IgG and IgA were present in 15 cases (34.1%) as compared to none of the controls. The difference between Chlamydia IgG, IgA and (IgG+IgA) among the cases and the controls were statistically significant. Majority of the participants positive for the immunoglobulins were aged 25 years or younger (11, 73.3%), number of lifetime sex partners and age of first sexual intercourse being 18 years or younger were statistically associated with Chlamydia trachomatis causing PID. Conclusion: Chlamydia trachomatis remains an important causative pathogen of PID and more prevalent among the young people. Screening is advocated among the young in resource limited countries.
  • Thumbnail Image
    Item
    Assessment of serological markers of genital chlamydia trachomatis infection among the gynaecology patients attending Babcock University teaching hospital, Ilishan-Remo, Ogun state, Nigeria.
    (2019) Ajani, T. A.; Elikwu, C. J.; Nwadike, V.; Babatunde, T.; Anaedobe, C. G.; Opeoluwa S.; Okangba, C.; Oluwasola, T. A. O.; Omeonu, A.; Faluyi, B.; Thompson, T. E.; Ebeigbe, E.; Ajani, M. A.; Joshua, A. K.; Kolawole, T.; Kristilere, H.; Meremikwu, C. M.; Mgbemena, L.; Nwaejike, C. S.; Salami, A.; Tantua, A.; Timothy, M.; Akagbusum, T.; Coker, A. O.
    Genital Chlamydia trachomatis infection causes significant morbidity and mortality in women. A number of epidemiologic studies have suggested that Polymerase Chain Reaction (PCR) is more accurate as a diagnostic tool for Chlamydia trachomatis.However, the use of serological markers may be cost effective and practical in diagnosing and estimating the burden of the disease in resource limited countries.This study was aimed at determining the serological markers (IgG, IgM and IgA) of Chlamydia trachomatis, evaluate the association between Chlamydia trachomatis infection and the sociodemographic characteristics and clinical diagnosis of the participants. This was a cross sectional hospital-based study in which blood samples from 145 consenting participants were tested for IgG, IgM and IgA antibodies against Chlamydia trachomatis using enzyme linked immunosorbent assay and their clinical diagnosis, retrieved from their case notes. The cumulative prevalence of seropositivity for Chlamydia trachomatis (IgG, IgM, IgA) was 112 (77.2%) while 33 (22.8%) were seronegative. The overall predominant seromarker was IgG 91(62.8%) while IgM and IgA accounted for 85(58.6%) and 54(37.2%) respectively. A statistically significant association was found between Chlamydia trachomatis infection and PID (p value = 0.031), primary infertility (p value 0.011) and level of income (p value= (0,045).